AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Physical Activity Intervention for MPS

Recruitingn/aAges 18 Years - anyAllBrunel University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Currently, treatments for mucopolysaccharidoses (MPS) are pharmacological and predominantly focus on the physical symptoms of the disease. In the general population and individuals with disabilities, increasing physical activity levels and reducing sedentary time can be an effective, non-pharmacological treatment to improve mental health and quality of life. Such interventions have not yet been developed or evaluated in people with MPS. The aim of this study is to co-design a physical activity and sedentary behaviour intervention tailored to the needs of adults with MPS. The study will seek to gain the expertise of adults with MPS, specialist stakeholders (physicians and clinical nurse specialists) and lay specialist stakeholders (family and friends of adults with MPS and members of staff and volunteers at the Society for Mucopolysaccharide Diseases). A range of views and experiences of

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Adults with Mucopolysaccharidosis will be eligible to participate in the study if they meet the following inclusion criteria: * Diagnosed with any type of Mucopolysaccharidosis. * Aged โ‰ฅ 18 years old. * Lives in the United Kingdom. * Deemed safe to participate by a clinician (for participatory workshops). Exclusion criteria for all participants will be as follows: * Incapacity to provide informed consent. * A level of intellectual disability that would prevent the individual from making a meaningful contribution to the focus groups or workshops. * Unable to communicate in English to a sufficient level to permit engagement in the study. The circumstances in which an individual may be deemed ineligible to take part in the participatory workshops based on the clinician's assessment are as follows: * Severe joint pain. * Neurological compromise. * Stage 4 heart failure or other condition resulting in breathlessness to a level they cannot participate. * Other clinical condition which dominates the clinical picture to the extent that it dominates the symptoms and influences the findings (e.g. stroke). Specialist stakeholders will be members of staff at NHS specialist centres for Mucopolysaccharidosis who are directly involved in healthcare provision to the target population. Lay specialist stakeholders will be individuals who have been involved in supporting adults with Mucopolysaccharidosis, such as family, friends, and members of staff and volunteers at the Society for Mucopolysaccharide Diseases.
๐Ÿ’Š

What it tests

  • Interviews/focus groups/participatory workshops
๐Ÿ“

Where

1 site
Brunel University London
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy